SCHEMBL9593697

SCHEMBL9593697

CCCCc1nc2ccc(C)cc2c(=O)n1Cc1ccc(OC(c2nnn[nH]2)c2cccc3ccccc23)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9590973 0.92 — —
SCHEMBL9592176 0.90 PDE4A (0.48) —
SCHEMBL9592404 0.86 NPC1 (0.45) —
SCHEMBL9592770 0.86 AGTR1 (0.39) —
SCHEMBL9590479 0.84 — —
SCHEMBL9591907 0.83 PDE4A (0.52) —
SCHEMBL9592146 0.83 — —
SCHEMBL9591861 0.83 AGTR1 (0.44) —
SCHEMBL9590508 0.82 AGTR1 (0.45) —
SCHEMBL9592046 0.81 PDE4A (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5264439-A Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element MERCK & CO., INC. (US) 1993-11-23 — — US disclosed
Send feedback